CN115212284A - Chinese medicinal compound for treating ischemic stroke and preparation method thereof - Google Patents
Chinese medicinal compound for treating ischemic stroke and preparation method thereof Download PDFInfo
- Publication number
- CN115212284A CN115212284A CN202211002459.6A CN202211002459A CN115212284A CN 115212284 A CN115212284 A CN 115212284A CN 202211002459 A CN202211002459 A CN 202211002459A CN 115212284 A CN115212284 A CN 115212284A
- Authority
- CN
- China
- Prior art keywords
- ischemic stroke
- honey
- ginger
- weight
- cassia twig
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000032382 Ischaemic stroke Diseases 0.000 title claims abstract description 27
- 150000001875 compounds Chemical class 0.000 title claims abstract description 21
- 238000002360 preparation method Methods 0.000 title description 8
- 239000003814 drug Substances 0.000 claims abstract description 55
- 240000001771 Euonymus fortunei Species 0.000 claims abstract description 31
- 244000197580 Poria cocos Species 0.000 claims abstract description 24
- 235000008599 Poria cocos Nutrition 0.000 claims abstract description 24
- 235000006886 Zingiber officinale Nutrition 0.000 claims abstract description 22
- 235000008397 ginger Nutrition 0.000 claims abstract description 22
- 244000037364 Cinnamomum aromaticum Species 0.000 claims abstract description 21
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims abstract description 21
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 17
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 17
- 235000017443 Hedysarum boreale Nutrition 0.000 claims abstract description 17
- 235000007858 Hedysarum occidentale Nutrition 0.000 claims abstract description 17
- 239000001947 glycyrrhiza glabra rhizome/root Substances 0.000 claims abstract description 17
- 244000131316 Panax pseudoginseng Species 0.000 claims abstract description 14
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims abstract description 14
- 241000005787 Cistanche Species 0.000 claims abstract description 11
- 244000273928 Zingiber officinale Species 0.000 claims abstract description 10
- 241000965722 Polygala fallax Species 0.000 claims abstract description 4
- 239000000843 powder Substances 0.000 claims description 25
- 241000218236 Cannabis Species 0.000 claims description 14
- 235000012907 honey Nutrition 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 10
- 238000005303 weighing Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 7
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 7
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 7
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 7
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 7
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 7
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 7
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 7
- 240000000171 Crataegus monogyna Species 0.000 claims description 7
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 7
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 239000006187 pill Substances 0.000 claims description 6
- 238000003756 stirring Methods 0.000 claims description 6
- 241000948950 Fallax Species 0.000 claims description 5
- 238000009835 boiling Methods 0.000 claims description 4
- 238000001914 filtration Methods 0.000 claims description 4
- 244000297179 Syringa vulgaris Species 0.000 claims description 2
- 235000004338 Syringa vulgaris Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 238000004898 kneading Methods 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims 1
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 229940079593 drug Drugs 0.000 abstract description 20
- 230000001737 promoting effect Effects 0.000 abstract description 17
- 210000000952 spleen Anatomy 0.000 abstract description 12
- 210000002784 stomach Anatomy 0.000 abstract description 12
- 230000001105 regulatory effect Effects 0.000 abstract description 11
- 208000024891 symptom Diseases 0.000 abstract description 11
- 230000017531 blood circulation Effects 0.000 abstract description 10
- 230000004087 circulation Effects 0.000 abstract description 10
- 235000001188 Peltandra virginica Nutrition 0.000 abstract description 8
- 230000001154 acute effect Effects 0.000 abstract description 7
- 230000001939 inductive effect Effects 0.000 abstract description 6
- 210000005036 nerve Anatomy 0.000 abstract description 6
- 230000001717 pathogenic effect Effects 0.000 abstract description 6
- 230000008093 supporting effect Effects 0.000 abstract description 6
- 230000002490 cerebral effect Effects 0.000 abstract description 5
- 208000004880 Polyuria Diseases 0.000 abstract description 4
- 230000035619 diuresis Effects 0.000 abstract description 4
- 244000052769 pathogen Species 0.000 abstract description 4
- 230000001976 improved effect Effects 0.000 abstract description 3
- 229940126680 traditional chinese medicines Drugs 0.000 abstract description 2
- 240000004308 marijuana Species 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 22
- 210000004369 blood Anatomy 0.000 description 22
- 206010062717 Increased upper airway secretion Diseases 0.000 description 14
- 208000026435 phlegm Diseases 0.000 description 14
- 241000234314 Zingiber Species 0.000 description 12
- 238000011282 treatment Methods 0.000 description 11
- 210000003205 muscle Anatomy 0.000 description 9
- 230000003213 activating effect Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 230000006870 function Effects 0.000 description 6
- 230000002040 relaxant effect Effects 0.000 description 6
- 230000008961 swelling Effects 0.000 description 6
- 208000006011 Stroke Diseases 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 210000002435 tendon Anatomy 0.000 description 5
- 230000008673 vomiting Effects 0.000 description 5
- 208000006820 Arthralgia Diseases 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 206010033557 Palpitations Diseases 0.000 description 4
- 208000007536 Thrombosis Diseases 0.000 description 4
- 230000011132 hemopoiesis Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000002107 myocardial effect Effects 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- 210000004916 vomit Anatomy 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 3
- 241000336291 Cistanche deserticola Species 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 208000032843 Hemorrhage Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 208000026106 cerebrovascular disease Diseases 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 230000000302 ischemic effect Effects 0.000 description 3
- 210000003127 knee Anatomy 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010008132 Cerebral thrombosis Diseases 0.000 description 2
- 206010011224 Cough Diseases 0.000 description 2
- 206010049119 Emotional distress Diseases 0.000 description 2
- 102000008946 Fibrinogen Human genes 0.000 description 2
- 108010049003 Fibrinogen Proteins 0.000 description 2
- 208000018779 Globus Sensation Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 208000037093 Menstruation Disturbances Diseases 0.000 description 2
- 206010027339 Menstruation irregular Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 206010040007 Sense of oppression Diseases 0.000 description 2
- 206010067868 Skin mass Diseases 0.000 description 2
- 102000003978 Tissue Plasminogen Activator Human genes 0.000 description 2
- 108090000373 Tissue Plasminogen Activator Proteins 0.000 description 2
- 230000003187 abdominal effect Effects 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 239000003146 anticoagulant agent Substances 0.000 description 2
- 229940127219 anticoagulant drug Drugs 0.000 description 2
- 206010003549 asthenia Diseases 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000009084 cardiovascular function Effects 0.000 description 2
- 210000000748 cardiovascular system Anatomy 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 208000012839 conversion disease Diseases 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000009429 distress Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940012952 fibrinogen Drugs 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 208000018997 giddiness Diseases 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 201000009240 nasopharyngitis Diseases 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 206010042772 syncope Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 229960000187 tissue plasminogen activator Drugs 0.000 description 2
- 231100000167 toxic agent Toxicity 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 230000002936 tranquilizing effect Effects 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 206010018985 Haemorrhage intracranial Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000016988 Hemorrhagic Stroke Diseases 0.000 description 1
- 208000008574 Intracranial Hemorrhages Diseases 0.000 description 1
- 241000209490 Nymphaea Species 0.000 description 1
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 241001619461 Poria <basidiomycete fungus> Species 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000032023 Signs and Symptoms Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 206010003230 arteritis Diseases 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 201000002676 cerebral atherosclerosis Diseases 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 208000013159 conscious disturbance Diseases 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000003527 fibrinolytic agent Substances 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 238000005534 hematocrit Methods 0.000 description 1
- 208000014951 hematologic disease Diseases 0.000 description 1
- 230000002439 hemostatic effect Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 208000020658 intracerebral hemorrhage Diseases 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000002640 perineum Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/37—Celastraceae (Staff-tree or Bittersweet family), e.g. tripterygium or spindletree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/64—Orobanchaceae (Broom-rape family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/906—Zingiberaceae (Ginger family)
- A61K36/9068—Zingiber, e.g. garden ginger
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine compound for treating ischemic stroke in the technical field of traditional Chinese medicines, which comprises euonymus fortunei, cassia twig, rhizoma atractylodis, rhizoma pinellinae praeparata, poria cocos, fructus crataegi nandinae, pseudo-ginseng, pericarpium citri reticulatae, polygala fallax hemsl, cistanche, fructus cannabis, ginger and radix glycyrrhizae preparata; the compound takes the euonymus fortunei as a main drug, and has the effects of dredging the dragon's road, promoting blood circulation and enabling the medicines to directly reach the skilful dock; rhizoma atractylodis, tuckahoe and rhizoma pinellinae praeparata are taken as the common medicines, and the traditional Chinese medicine can promote diuresis, eliminate dampness and regulate spleen and stomach to regulate 'grain channel'; ramulus Cinnamomi, fructus crataegi and radix Polygalae Fallacis are used as mother medicines for communicating exterior and interior yin and yang, inducing pathogen to go out, supporting healthy qi, and regulating water channel; the dried orange peel is used as a medicine for promoting the circulation of qi and regulating the middle warmer; ginger and prepared licorice root, radix Glycyrrhizae Praeparata. The prescription takes the principal and subordinate symptoms into consideration, and the cassia twig, the ginger and the like which are used for opening the upper jiao are added with the poria cocos, the dried orange peel and the like which are used for opening the middle jiao to regulate the grain channel and the water channel, so that the dragon road fire is dredged, the two ways run normally, and the three ways are plugged, and the cerebral circulation and the nerve function of the patient with the ischemic stroke in the acute stage are improved.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine compound for treating ischemic stroke and a preparation method thereof.
Background
Ischemic stroke refers to the biased development and conscious disturbance caused by cerebral infarction and cerebral artery obstruction on the basis of cerebral thrombosis or cerebral thrombosis, compared with hemorrhagic stroke, the ischemic stroke is slow in onset and often has premonitory symptoms, so that the 'golden time window' of treating ischemic stroke needs to be better maintained for 4.5 hours.
The therapeutic principle for ischemic stroke is to dissolve the thrombus as early as possible and to re-open the blood vessel. Conventional therapeutic approaches include western medicine treatments, such as tissue plasminogen activator (t-PA), an anticoagulant, but this drug carries the risk of intracranial hemorrhage; surgical treatment, such as neuro-intervention, by cutting a small opening at the perineum, introducing thrombolytic drugs into the blood vessel by means of a catheter with a large volume, and navigating the micro-catheter to the obstruction position in the brain by a micro-guide wire, but the method can be provided only by a comprehensive stroke treatment center, and the risk of missing gold treatment time exists for patients in the acute stage; traditional Chinese medicine treatment can take effect slowly although the root causes are treated, and is more suitable for the recovery period, so that when treating ischemic stroke, doctors often combine the traditional Chinese medicine and western medicine treatment means to treat patients with stroke, and in order to strive for longer treatment time for patients in the acute period, a traditional Chinese medicine compound for improving cerebral circulation and nerve functions of patients with ischemic stroke and a preparation method thereof are provided.
Disclosure of Invention
In order to solve the problems, the invention aims to provide a traditional Chinese medicine compound for treating ischemic stroke and a preparation method thereof.
In order to achieve the purpose, the technical scheme of the invention is as follows: a Chinese medicinal compound for the treatment of ischemic apoplexy and its preparation method, its raw material medicine includes Euonymus fortunei 15-25g, ramulus Cinnamomi 10-20g, rhizoma Atractylodis 10-20g, rhizoma Pinelliae Preparata 15-25g, poria 10-20g, fructus crataegi 15-25g, notoginseng radix 10-20g, pericarpium Citri Tangerinae 10-20g, herba Polygalae Fallacis 10-20g, cistanchis herba 10-20g, fructus Cannabis 10-20g, rhizoma Zingiberis recens 10-20g, radix Glycyrrhizae Preparata 2-8g,
a Chinese medicinal composition for treating ischemic apoplexy and its preparation method: weighing euonymus fortunei by weight, decocting the euonymus fortunei in water for 3 times, extracting one third of euonymus fortunei in 1.5 hours for the first time, extracting one half of euonymus fortunei in 1 hour for the second time, extracting the rest of decoction in 0.5 hour for the third time, combining the decoctions, filtering, concentrating into clear paste, drying, and crushing to obtain first fine powder; weighing rhizoma atractylodis, rhizoma pinellinae praeparata and poria cocos according to parts by weight, mixing, putting into a vessel, drying and then crushing to obtain second fine powder; weighing cassia twig, south hawthorn and manyflower yellowflower water lily according to parts by weight, mixing, putting into a vessel, adding water, decocting, boiling with strong fire for 10-20 minutes, decocting with slow fire for 60 minutes, filtering, concentrating into clear paste, drying, and crushing to obtain third fine powder; weighing dried orange peel, cistanche, fructus cannabis, ginger, honey-fried licorice root and pseudo-ginseng according to the weight parts, respectively crushing, pouring all fine powder into a vessel, and uniformly stirring for later use; adding the honey with the same weight as the medicinal powder into a pot, slowly heating with slow fire until boiling to obtain small and dense bubbles, pouring the honey into the medicinal powder when the bubbles are large, stirring with chopsticks, and kneading the large block masses with hands when the small block masses are small to ensure the hardness of the medicinal powder to be consistent, and uniformly cooling the medicinal powder and honey to obtain the Chinese medicinal pills with consistent size.
After the scheme is adopted, the following beneficial effects are realized:
wintercreeper: has tranquilizing, analgesic, anticoagulant, qi and blood invigorating, liver and kidney nourishing, muscles and tendons relaxing, collateral flow activating, hemostatic, and blood stasis removing effects.
Rhizoma atractylodis: has effects of dredging meridian passage, and can be used for resisting thrombi, promoting hematopoiesis, relieving swelling and pain.
Rhizoma pinelliae preparata: eliminating dampness and phlegm, lowering adverse qi and relieving vomit, relieving oppression and resolving masses, and improving cardiovascular function, and can be used for treating damp phlegm cough, wind phlegm giddiness, phlegm syncope headache, emesis and regurgitation, chest and gastric cavity stuffiness and distress, globus hystericus, goiter tumor, subcutaneous nodule, superficial infection and pyogenic infections.
Tuckahoe, poria cocos: has effects of removing toxic substance, eliminating dampness, and relieving arthralgia, and is mainly used for relieving rigidity of muscles and activating collaterals.
Cassia twig: has effects of inducing sweat, expelling pathogenic factors from muscles, warming and dredging channels and collaterals, supporting yang, regulating qi, and calming the adverse-rising energy, and can be used for treating wind-cold type common cold, abdominal psychroalgia, blood cold, amenorrhea, arthralgia, phlegm retention, edema, and palpitation.
South hawthorn: has effects of resolving food stagnation, removing qi stagnation, removing blood stasis, lowering blood pressure, increasing coronary blood flow, and reducing blood lipid for cardiovascular system.
Radix Polygalae Fallacis: has the effects of tonifying, strengthening, eliminating dampness and removing blood stasis, and is mainly used for relaxing muscles and tendons, activating collaterals, and treating jaundice and irregular menstruation.
Dried orange peel: has the effects of regulating qi, strengthening spleen, eliminating dampness and phlegm, and can be used for treating spleen and stomach qi stagnation syndrome and phlegm-damp stagnation syndrome.
Cistanche deserticola: has the effects of invigorating kidney yang, replenishing essence and blood, and loosening bowel to relieve constipation, and can be used for: impotence, infertility, soreness and weakness of the waist and knees, weakness of the bones and muscles, constipation due to intestinal dryness.
Fructus cannabis: moistening dryness, relaxing bowels, tonifying deficiency, promoting myocardial contraction, improving oxygen uptake of myocardial cells, and promoting blood circulation.
Ginger: has effects in promoting blood circulation, dispelling cold, eliminating dampness, promoting perspiration, invigorating stomach, relieving vomit, eliminating fishy smell, and eliminating edema.
Honey-fried licorice root: tonify spleen and stomach, benefit qi and recover pulse. Can be used for treating weakness of spleen and stomach, asthenia, palpitation, and intermittent pulse, and can relieve subsidiary toxicity.
Pseudo-ginseng: has the effects of removing blood stasis, stopping bleeding, relieving swelling and relieving pain, and is mainly used for resisting thrombus, promoting hematopoiesis, relieving swelling and relieving pain, and the like.
The drug effect of the euonymus fortunei can be fully exerted by decocting the euonymus fortunei for three times and respectively extracting decoction liquid, and the euonymus fortunei is taken as a main drug to promote the circulation of blood and lead the medicine to directly reach the skilful dock; rhizoma atractylodis, tuckahoe and rhizoma pinellinae praeparata are used as the common medicines for promoting diuresis and eliminating dampness and regulating the function of the spleen and stomach to dredge the 'valley way'; ramulus Cinnamomi, fructus crataegi and radix Polygalae Fallacis are used as mother medicines for communicating exterior and interior yin and yang, inducing pathogen to go out, supporting healthy qi, and regulating water channel; the dried orange peel is used as a medicine for promoting the circulation of qi and regulating the middle warmer; ginger and prepared licorice root, radix Glycyrrhizae Praeparata. The prescription gives consideration to both symptoms and root causes, and cassia twig, ginger and the like which are used for opening the upper jiao are added with tuckahoe, dried orange peel and the like which are used for opening the middle jiao to regulate the grain passage and the water passage, so that the Longlu fire is dredged, two ways are normally operated, and three ways are unblocked, and the cerebral circulation and the nerve function of a patient with ischemic stroke in the acute stage are improved.
Detailed Description
The following is a more detailed description of the present invention by way of specific embodiments.
The specific implementation process is as follows:
example one
A traditional Chinese medicine compound for treating ischemic stroke comprises, by weight, 15-25g of euonymus fortunei, 10-20g of cassia twig, 10-20g of rhizoma atractylodis, 15-25g of rhizoma pinellinae praeparata, 10-20g of poria cocos, 15-25g of hawthorn, 10-20g of pseudo-ginseng, 10-20g of pericarpium citri reticulatae, 10-20g of polygala fallax hemsl, 10-20g of cistanche deserticola, 10-20g of fructus cannabis, 10-20g of ginger and 2-8g of honey-fried licorice root.
Example two
A traditional Chinese medicine compound for treating ischemic stroke comprises the following raw materials in parts by weight: 15g of euonymus fortunei, 10g of cassia twig, 10g of rhizoma atractylodis, 15g of rhizoma pinellinae praeparata, 10g of poria cocos, 15g of fructus crataegi cuneatae, 10g of pseudo-ginseng, 10g of dried orange peel, 10g of radix polygalae fallax, 10g of cistanche, 10g of fructus cannabis, 10g of ginger and 2g of honey-fried licorice root
EXAMPLE III
A traditional Chinese medicine compound for treating ischemic stroke comprises the following raw materials in parts by weight: 20g of euonymus fortunei, 15g of cassia twig, 15g of rhizoma atractylodis, 20g of rhizoma pinellinae praeparata, 15g of poria cocos, 20g of fructus crataegi cuneatae, 15g of pseudo-ginseng, 15g of pericarpium citri reticulatae, 15g of radix polygalae fallax, 15g of cistanche, 15g of fructus cannabis, 15g of ginger and 5g of honey-fried licorice root
Example four
A traditional Chinese medicine compound for treating ischemic stroke comprises the following raw materials in parts by weight: 25g of euonymus fortunei, 20g of cassia twig, 20g of rhizoma atractylodis, 25g of rhizoma pinellinae praeparata, 20g of poria cocos, 25g of fructus crataegi cuneatae, 20g of pseudo-ginseng, 20g of pericarpium citri reticulatae, 20g of radix polygalae fallax, 20g of cistanche, 20g of fructus cannabis, 20g of ginger and 8g of honey-fried licorice root
EXAMPLE five
A Chinese medicinal compound for the treatment of ischemic apoplexy and its preparation method, including the following step, weigh Euonymus fortunei according to the part by weight, euonymus fortunei is decocted in water for 3 times, extract one third in decocting 1.5 hours for the first time, extract one half after decocting 1 hour for the second time, extract the remaining decoction after decocting 0.5 hours for the third time, mix the decoction, filter, concentrate into supernate, oven dry, pulverize, get the first furfurescence; weighing rhizoma atractylodis, rhizoma pinellinae praeparata and poria cocos according to parts by weight, mixing, putting into a vessel, drying and then crushing to obtain second fine powder; weighing cassia twig, south hawthorn and manyflower lilac flower in parts by weight, mixing, putting into a vessel, adding water, decocting, boiling with strong fire for 10-20 minutes, decocting with slow fire for 60 minutes, filtering, concentrating into clear paste, drying and crushing to obtain third fine powder; weighing dried orange peel, cistanche, fructus cannabis, ginger, honey-fried licorice root and pseudo-ginseng according to the weight parts, respectively crushing, pouring all fine powder into a vessel, and uniformly stirring for later use; the honey with the same weight as the medicinal powder is taken and put into a pot, the pot is slowly heated by small fire until the honey is boiled to generate small and dense bubbles, when the small bubbles are changed into big bubbles, the honey is poured into the medicinal powder while the honey is hot, the chopsticks are used for stirring continuously, when the big block masses are reduced, the honey can be kneaded by hand, all the medicinal powder is blended together, the hardness of the medicinal powder is ensured to be consistent, and after the medicinal powder and the honey are uniform, the medicinal powder and the honey are not cooled and are evenly divided into Chinese medicine pills with the same size as soon as possible. The weight parts of the raw materials in the examples are selected according to any one of the first to fourth examples.
In the above medicament, wherein:
wintercreeper: has tranquilizing, analgesic, and anticoagulant effects, and can be used for invigorating qi and blood, nourishing liver and kidney, relaxing muscles and tendons, activating collateral flow, stopping bleeding, and dispelling blood stasis.
And (5) rhizoma atractylodis: has effects of dredging meridian passage, and can be used for resisting thrombi, promoting hematopoiesis, relieving swelling and pain.
Rhizoma pinelliae preparata: eliminating dampness and phlegm, lowering adverse qi and relieving vomit, relieving oppression and resolving masses, and improving cardiovascular function, and can be used for treating damp phlegm cough, wind phlegm giddiness, phlegm syncope headache, emesis and regurgitation, chest and gastric cavity stuffiness and distress, globus hystericus, goiter tumor, subcutaneous nodule, superficial infection and pyogenic infections.
Tuckahoe, poria cocos: has effects of removing toxic substance, eliminating dampness, and relieving arthralgia, and is mainly used for relieving rigidity of muscles and activating collaterals.
Cassia twig: has effects of inducing sweat, expelling pathogenic factors from muscles, warming and activating channels, supporting yang, regulating qi-flowing, and calming the adverse-rising energy, and can be used for treating wind-cold type common cold, abdominal psychroalgia, blood cold type amenorrhea, arthralgia, phlegm and fluid retention, edema, and palpitation.
South hawthorn: has effects of resolving food stagnation, removing qi stagnation, dispelling blood stasis, lowering blood pressure, increasing coronary blood flow, and reducing blood lipid for cardiovascular system.
Radix Polygalae Fallacis: has the effects of tonifying, strengthening, eliminating dampness and removing blood stasis, and is mainly used for relaxing muscles and tendons, activating collaterals, and treating jaundice and irregular menstruation.
Dried orange peel: has the effects of regulating qi, strengthening spleen, eliminating dampness and phlegm, and can be used for treating spleen and stomach qi stagnation syndrome and phlegm-damp stagnation syndrome.
Cistanche deserticola: has the effects of invigorating kidney yang, nourishing essence and blood, and loosening bowel to relieve constipation, and can be used for: impotence, infertility, soreness and weakness of the loins and knees, weakness of tendons and bones, constipation due to intestinal dryness.
Fructus cannabis: moistening dryness, relaxing bowels, tonifying deficiency, promoting myocardial contraction, improving oxygen uptake of myocardial cells, and promoting blood circulation.
Ginger: has effects in promoting blood circulation, dispelling cold, eliminating dampness, promoting perspiration, invigorating stomach, relieving vomit, expelling fishy smell, and eliminating edema.
Honey-fried licorice root: tonify spleen and stomach, replenish qi and recover pulse. Can be used for treating weakness of spleen and stomach, asthenia, palpitation, and intermittent pulse, and can relieve subsidiary toxicity.
Pseudo-ginseng: has the effects of removing blood stasis, stopping bleeding, relieving swelling and relieving pain, and is mainly used for resisting thrombus, promoting hematopoiesis, relieving swelling and relieving pain, and the like.
The medicine is prepared from 13 medicines of euonymus fortunei, cassia twig, rhizoma atractylodis and the like according to the matching principle of strong prescription. In the formula, euonymus fortunei is used as a main drug, and is used for dredging the dragon road and promoting blood circulation, so that the medicine can directly reach the skilful dock; rhizoma atractylodis, tuckahoe and rhizoma pinellinae praeparata are taken as the common medicines, and the traditional Chinese medicine can promote diuresis, eliminate dampness and regulate spleen and stomach to regulate 'grain channel'; ramulus Cinnamomi, fructus crataegi and radix Polygalae Fallacis are used as mother medicines for communicating exterior and interior yin and yang, inducing pathogen to go out, supporting healthy qi, and regulating water channel; the dried orange peel is used as an assistant drug to promote the circulation of qi and harmonize the middle; ginger and prepared licorice root, radix Glycyrrhizae Praeparata. The prescription gives consideration to both symptoms and root causes, and cassia twig, ginger and the like which are used for opening the upper jiao are added with tuckahoe, dried orange peel and the like which are used for opening the middle jiao to regulate the grain passage and the water passage, so that the Longlu fire is dredged, two ways are normally operated, and three ways are unblocked, and the cerebral circulation and the nerve function of a patient with ischemic stroke in the acute stage are improved.
The product of the invention is a traditional Chinese medicine pill, is more convenient for patients to carry, can be taken orally immediately when suffering from ischemic stroke, can strive for more time for hospital treatment, and patients in convalescent period can also take the medicine to continuously improve cerebral circulation and nerve functions.
Clinical experiments show that the method has good beneficial technical effects, and the relevant experimental data are as follows:
1. general data
1.1 case origin: the cases were from: 32 outpatients, 68 wards, 100 cases, wherein 72 men and 28 women are in 28 cases, the age is 35-70 years, and the average age is 50 years; the course of the disease is more than 2 hours and within 30 days.
1.2 case selection
1.2.1 Western diagnostic criteria: refer to the fourth revised diagnostic principle of cerebrovascular diseases of the third national academy of cerebrovascular diseases of the Chinese medical society in 1995. All cases met the following conditions: frequently, the disease occurs in a quiet state. Most of the cases were without significant headache and vomiting. The onset of the disease is slow, gradual or stage, and is usually related to cerebral atherosclerosis, such as arteritis and blood diseases. Clear consciousness or mild disturbance within 1-2 days after the onset of the disease. There are symptoms and signs of the internal carotid and/or basilar arterial systems. A cranial CT or MRI examination should be performed. Cerebrospinal fluid for lumbar puncture should generally not contain blood.
1.2.2 Chinese medicine diagnosis standard: the main symptoms are: hemiplegia, coma, slurred speech or aphasia, abnormal sensation of the body and tongue. The secondary symptoms are as follows: restlessness, insomnia, soreness and weakness of the loins and knees, vertigo, tinnitus, spasm or peristalsis of the hands and feet, dark tongue with thin and small coating, and wiry, thready or deep and thready pulse. Acute onset usually has a predisposing cause before onset, and a premonitory symptom is usually observed. The onset age is usually 40 years or older. The diagnosis can be confirmed by combining the onset, the cause, the premonitory symptoms and the age, wherein the number of the main symptoms is more than 2, or 1 main symptom and 2 secondary symptoms; without the above conditions, the diagnosis can be confirmed by combining the results of the imaging examination.
2. The treatment method comprises the following steps: the traditional Chinese medicine pill for treating ischemic stroke is taken three weeks, 3 pills each time and three times a day, and can be taken by patients in acute stage when the patients suffer from the diseases.
3. And (3) observation indexes are as follows: hemorheology
4. Statistical treatment
TABLE 4-1 comparison of index changes (x. + -. S) of the haemorheology before and after treatment
| Before taking | After taking | |
| Whole blood high shear viscosity (mPa. S) | 5.97±0.42 | 5.16±0.11* |
| Whole blood Low cut viscosity (mPa. S) | 9.13±1.62 | 6.97±1.42* |
| Specific viscosity of plasma (mPa. S) | 3.97±1.32 | 1.87±0.92** |
| Fibrinogen (g/L) | 4.51±0.47 | 2.97±0.79* |
| Packed cell volume (%) | 45.97±5.42 | 37.15±3.77* |
Note: * Represents P < 0.05 compared with the medicine before taking
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered as the technical solutions and the inventive concepts of the present invention within the technical scope of the present invention.
5. Conclusion
Clinical results show that the invention can improve the blood circulation and the nerve function of the brain of a patient, and reduce various blood flow indexes such as whole blood specific viscosity, plasma specific viscosity, hematocrit, fibrinogen and the like. The Chinese medicine compound is prepared from 13 medicines such as euonymus fortunei, cassia twig, rhizoma atractylodis and the like, can resist thrombus, eliminate stasis and relieve pain, and the euonymus fortunei is used as a main medicine, is used for dredging the dragon road and activating blood, and leads the medicines to directly reach the skilful dock; rhizoma atractylodis, tuckahoe and rhizoma pinellinae praeparata are taken as the common medicines, and the traditional Chinese medicine can promote diuresis, eliminate dampness and regulate spleen and stomach to regulate 'grain channel'; ramulus Cinnamomi, fructus crataegi, and radix Polygalae Fallacis as mother medicines for communicating yin and yang, inducing pathogen to go out, supporting vital qi, and regulating water channel; the dried orange peel is used as an assistant drug to promote the circulation of qi and harmonize the middle; ginger and prepared licorice root, radix Glycyrrhizae Praeparata. The prescription gives consideration to both principal and secondary aspects, and cassia twig, ginger and the like which are opened to the upper part of the body are added with poria cocos, dried orange peel and the like which are opened to the middle part of the body to regulate the grain passage and the water passage, so that the dragon road fire is dredged, two ways of medicines run normally, and three ways of medicines are plugged.
The foregoing is merely an example of the present invention and common general knowledge in the art of specific structures and/or features of the invention has not been set forth herein in any way. It should be noted that, for those skilled in the art, without departing from the structure of the present invention, several changes and modifications can be made, which should also be regarded as the protection scope of the present invention, and these will not affect the effect of the implementation of the present invention and the practicability of the patent. The scope of the claims of the present application shall be determined by the contents of the claims, and the description of the embodiments and the like in the specification shall be used to explain the contents of the claims.
Claims (7)
1. A traditional Chinese medicine compound for treating ischemic stroke is characterized by comprising the following raw materials in parts by weight: 15-25g of euonymus fortunei, 10-20g of cassia twig, 10-20g of rhizoma atractylodis, 15-25g of rhizoma pinellinae praeparata, 10-20g of poria cocos, 15-25g of fructus crataegi cuneatae, 10-20g of pseudo-ginseng, 10-20g of dried orange peel, 10-20g of polygala fallax hemsl, 10-20g of cistanche, 10-20g of fructus cannabis, 10-20g of ginger and 2-8g of honey-fried licorice root.
2. The traditional Chinese medicine compound for treating ischemic stroke according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 15g of euonymus fortunei, 10g of cassia twig, 10g of rhizoma atractylodis, 15g of rhizoma pinellinae praeparata, 10g of poria cocos, 15g of fructus crataegi cuneatae, 10g of pseudo-ginseng, 10g of pericarpium citri reticulatae, 10g of radix polygalae fallax, 10g of cistanche, 10g of fructus cannabis, 10g of ginger and 2g of honey-fried licorice root.
3. The traditional Chinese medicine compound for treating ischemic stroke according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 20g of euonymus fortunei, 15g of cassia twig, 15g of rhizoma atractylodis, 20g of rhizoma pinellinae praeparata, 15g of poria cocos, 20g of fructus crataegi cuneatae, 15g of pseudo-ginseng, 15g of pericarpium citri reticulatae, 15g of radix polygalae fallax, 15g of cistanche, 15g of fructus cannabis, 15g of ginger and 5g of honey-fried licorice root.
4. The traditional Chinese medicine compound for treating ischemic stroke according to claim 1, which is characterized by comprising the following raw materials in parts by weight: 25g of euonymus fortunei, 20g of cassia twig, 20g of rhizoma atractylodis, 25g of rhizoma pinellinae praeparata, 20g of poria cocos, 25g of fructus crataegi cuneatae, 20g of pseudo-ginseng, 20g of pericarpium citri reticulatae, 20g of polygala fallax hemsl, 20g of cistanche, 20g of fructus cannabis, 20g of ginger and 8g of honey-fried licorice root.
5. The method for preparing a Chinese herbal compound for treating ischemic stroke according to any one of claims 1 to 4, characterized in that the wintercreeper is weighed according to the parts by weight, the wintercreeper is decocted in water for 3 times, the decoction is merged, filtered, concentrated into clear paste, dried and crushed to obtain first fine powder; weighing rhizoma atractylodis, rhizoma pinellinae praeparata and poria cocos according to the parts by weight, mixing, putting into a vessel, drying and then crushing to obtain second fine powder; weighing cassia twig, south hawthorn and manyflower lilac flower in parts by weight, mixing, putting into a vessel, adding water, decocting for 1 time, filtering, concentrating into clear paste, drying and crushing to obtain third fine powder; weighing dried orange peel, cistanche, fructus cannabis, ginger, honey-fried licorice root and pseudo-ginseng according to the weight parts, respectively crushing, pouring all fine powder into a vessel, and uniformly stirring for later use; adding the honey with the same weight as the medicinal powder into a pot, slowly heating with slow fire until boiling to obtain small and dense bubbles, pouring the honey into the medicinal powder when the bubbles are large, stirring with chopsticks, and kneading the large block masses with hands when the small block masses are small to ensure the hardness of the medicinal powder to be consistent, and uniformly cooling the medicinal powder and honey to obtain the Chinese medicinal pills with consistent size.
6. The method for preparing a Chinese herbal compound prescription for treating ischemic stroke according to claim 5, characterized in that the euonymus fortunei is decocted with slow fire for three times by adding water, one third of the euonymus fortunei is extracted after 1.5 hours of decoction for the first time, one half of the euonymus fortunei is extracted after 1 hour of continuous decoction for the second time, and the rest of decoction is extracted after 0.5 hour of continuous decoction for the third time.
7. The method for preparing a compound Chinese medicine for treating ischemic stroke as claimed in claim 5, wherein the cassia twig, the south hawthorn fruit and the radix astragali Sinici are boiled with strong fire for 10-20 minutes and then decocted with slow fire for 60 minutes when they are mixed and decocted.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211002459.6A CN115212284A (en) | 2022-08-22 | 2022-08-22 | Chinese medicinal compound for treating ischemic stroke and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202211002459.6A CN115212284A (en) | 2022-08-22 | 2022-08-22 | Chinese medicinal compound for treating ischemic stroke and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN115212284A true CN115212284A (en) | 2022-10-21 |
Family
ID=83615439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202211002459.6A Pending CN115212284A (en) | 2022-08-22 | 2022-08-22 | Chinese medicinal compound for treating ischemic stroke and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN115212284A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116392540A (en) * | 2023-03-14 | 2023-07-07 | 广西国际壮医医院 | Jinxiangxueyu vine drink for relieving stroke depression and preparation method thereof |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729580A (en) * | 2017-02-14 | 2017-05-31 | 广西中医药大学第附属医院 | Treat the Chinese medicine of apoplexy at acute stage |
| CN111671884A (en) * | 2020-07-24 | 2020-09-18 | 广西国际壮医医院 | Pharmaceutical composition for treating cerebral apoplexy and depression caused by cerebral apoplexy and production method thereof |
-
2022
- 2022-08-22 CN CN202211002459.6A patent/CN115212284A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106729580A (en) * | 2017-02-14 | 2017-05-31 | 广西中医药大学第附属医院 | Treat the Chinese medicine of apoplexy at acute stage |
| CN111671884A (en) * | 2020-07-24 | 2020-09-18 | 广西国际壮医医院 | Pharmaceutical composition for treating cerebral apoplexy and depression caused by cerebral apoplexy and production method thereof |
Non-Patent Citations (1)
| Title |
|---|
| 陈晓锋,等: "壮通饮治疗恢复期脑梗死60例临床观察" * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116392540A (en) * | 2023-03-14 | 2023-07-07 | 广西国际壮医医院 | Jinxiangxueyu vine drink for relieving stroke depression and preparation method thereof |
| CN116392540B (en) * | 2023-03-14 | 2024-01-30 | 广西国际壮医医院 | Jinxiangxueyu vine drink for relieving stroke depression and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
| CN102166317B (en) | Traditional Chinese medicine combination for curing metrorrhagia and metrostaxis | |
| CN101095768B (en) | Chinese traditional medicine capsule for treating primary hypertension for persons in middle and old age | |
| CN115212284A (en) | Chinese medicinal compound for treating ischemic stroke and preparation method thereof | |
| CN102671141A (en) | Chinese medicine for curing hyperplasia of mammary glands | |
| CN102861270B (en) | Muscular and bone pain relieving medicinal liquor for treating ankylosing spondylitis | |
| CN102847074B (en) | Blood stasis removing pill for treating ankylosing spondylitis | |
| CN105055849A (en) | Traditional Chinese medicine extract capable of nourishing Yin and tonifying kidney as well as preparation method and application of traditional Chinese medicine extract | |
| CN104225166A (en) | Chinese medicine composition for treating amenorrhea and preparation method thereof | |
| CN101607067B (en) | Traditional Chinese medicine preparation for treating cholelithiasis and preparation method thereof | |
| CN106310023A (en) | Drug for treating small cell lung cancer, and preparation method and application thereof | |
| CN102357227A (en) | Chinese medicinal composition for treating qi stagnation and blood stasis amenorrhea | |
| CN105311492A (en) | Medicine for treating coronary atherosclerotic heart disease | |
| CN102614462B (en) | Traditional Chinese medicine composition for curing coronary disease and preparation method thereof | |
| CN104857311A (en) | Traditional Chinese medicine for treating ischemic necrosis of femoral head | |
| CN104173987A (en) | Traditional Chinese medicine for treating postpartum hemorrhage caused by blood stasis and qi obstruction and preparation method thereof | |
| CN106620402A (en) | Traditional Chinese medicine composition taken after operation of liver cancer and preparation method thereof | |
| CN111973720A (en) | A Chinese medicinal composition for treating mastitis and hyperplasia of mammary glands, and its preparation method | |
| CN108785421B (en) | A Chinese medicinal composition for treating fracture and its preparation method | |
| CN105362629A (en) | Female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae and preparation method of female climacteric syndrome treatment pharmaceutical composition containing cortex eucommiae | |
| CN101085303A (en) | Oral administration traditional Chinese medicine composition for treating hyperplasia of mammary glands | |
| CN117860842B (en) | Acupoint patch for endometrial repair and application thereof | |
| CN103690644B (en) | Promote the Chinese medicine preparation of fracture recovering | |
| CN102274472A (en) | Traditional Chinese medicine patch for treating female dysmenorrhoea and preparation thereof | |
| CN105535719A (en) | Medicine composition for treating blood stasis type amenorrhoea |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20221021 |